While developing an assay to measure the activity of the tat protein from human immunodeficiency virus 1 (HIV-l), we discovered that the purified protein could be taken up by cells growing in tissue culture and subsequently trans-activate the viral promoter. Transactivation is dramatically increased by a variety of lysosomotrophic agents. For example, trans-activation can be detected at tat concentrations as low as 1 nM in the presence of chloroquine. Experiments using radioactive protein show that tat becomes localized to the nucleus after uptake and suggest that chloroquine protects tat from proteolytic degradation. These results raise the possibility that, under some conditions, tat might act as a viral growth factor to stimulate viral replication in latently infected cells or alter expression of cellular genes.
Introduction
The human immunodeficiency virus (HIV) encodes several regulatory proteins that are not found in other retroviruses. The tat protein, which is one of these regulatory proteins, trans-activates genes that are expressed from the HIV long terminal repeat (LTR) (Sodroski et al., 1985b) , and tat is essential for viral replication in vitro (Fisher et al., 1986; Dayton et al., 1986) . Although the precise mechanism of trans-activation remains controversial, tat appears to be localized to the nucleus (Hauber et al., 1987) , and a region of about 50 bp near the 3' end of the viral promoter (the TAR site) is necessary for trans-activation by tat (Rosen et al., 1985; Hauber and Cullen, 1988; Jakobovits et al., 1988) . Purified tat does not seem to bind specifically to the TAR site (Frankel et al., 1988a) , but binding of cellular proteins in this region (in the absence of tat) has been observed (Garcia et al., 1987; Wu et al., 1988) .
The tat protein is 86 amino acids long and contains a highly basic region (with two lysines and six arginines) and a cysteine-rich region (with seven cysteines in 16 residues) (Arya et al., 1985; Sodroski et al., 1985a) . We have recently shown that purified tat can form metallinked dimers (Frankel et al., 1988a) and that a peptide containing just the cysteine-rich region of tat can mimic the dimer interface (Frankel et al., 1988b) . To test the biological relevance of these studies and to test effects of possible inhibitors, we needed a convenient assay for tat. In this paper, we describe a simple rrans-activation assay, and also report the surprising observation that purified tat protein can be taken up by cells and rrans-activate the HIV-1 promoter.
Results
In an attempt to develop a convenient assay for the tat protein, we tried to find simple ways to introduce purified protein into cells containing a reporter gene (chloramphenicol acetyltransferase;
CAT) under the control of the HIV-l LTR. After trying several methods, we found that "scrapeloading" (McNeil et al., 1984) was a convenient method that gave quantitative and reproducible rrans-activation of the HIV-l promoter. It is believed that scrape-loading transiently damages the cell membrane and allows molecules present in the culture medium to equilibrate with the cytoplasm.
Figures 1A and 1B show that purified tat protein introduced into cells by scrape-loading efficiently rrans-activates the HIV-1 promoter, and that the amount of CAT activity is proportional to the amount of tat protein present at loading. Trans-activation from as little as 100 ng of tat protein could be detected, and the dose response was linear over a large concentration range. Typically, cells were loaded in 5 ml of medium (in 60 mm dishes), although rrans-activation could be significantly improved by scraping in smaller volumes ( Figure 1C ). CAT activity reached a plateau 24 hr after scrape-loading.
Carboxymethylation of the cysteines by iodoacetic acid (a covalent modification) completely eliminated activity (data not shown), suggesting that at least some cysteines are necessary for rrans-activation. This is a simple and sensitive assay for tat, and the results demonstrate that the tat protein produced in bacteria is active when introduced into mammalian cells. An unexpected result was seen when purified tat was simply added to the culture medium of HL3Tl cells: Expression of CAT from the integrated HIV-1 promoter increased and was proportional to the tat concentration ( Figure 2 ). Additional small increases in activity (2-to 3-fold) were observed upon addition of 10 mM zinc or 1 mM cadmium, suggesting that metals might stabilize tat either during uptake or once inside the cell. As with scrapeloading, CAT activity did not increase further after 24 hr.
To explore the uptake process further, we examined the effects of various lysosomotrophic agents that might be expected to inhibit receptor-mediated endocytosis (Mellman et al., 1986) . We observed a dramatic stimulation of tat activity when the weak bases, chloroquine or amantadine, or the carboxylic ionophore, monensin, were added ( Figure 3 ). Thi? level of trans-activation by 5 vg of tat with chloroquine present was about 7000-fold compared with untreated cells, whereas chloroquine gave little increase in promoter activity in the absence of tat (Figure 3 ). Methylamine also significantly increased Rafts-activation, whereas ammonium chloride only slightly increased activity. No lysosomotrophic agent tested significantly activated the promoter in the absence of tat. Two micrograms of tat were scrape-loaded in the volumes indicated. After incubating for 3 hr. medium was added to bring the total volume to 5 ml
The parameters of chloroquine-stimulated tat activity time course of tat trans-activation in the presence of chlowere studied in more detail. The concentration depenroquine showed a plateau after 24 hr ( Figure 4EJ ), and dence of chloroquine showed a rather sharp dose refrans-activation in the presence of chloroquine increased sponse with maximum trans-activation observed at 100 with increasing tat concentration ( Figure 4C ). Trans-acti-PM chloroquine ( Figure 4A ). This concentration is typivation was detectable with tat concentrations as low as cally used to raise vacuolar pH (Mellman et al., 1986) HL3Tl cells were incubated with protein for 24 hr, the medium was replaced, and CAT activity was determined after 60 hr. Trans-activahon of the HIV-l LTR is normalized to basal expression of CAT.
Controls were done to determine whether frans-activation was dependent on an intact TAR site, to determine whether a heterologous promoter could be stimulated by tat, and to determine whether any of the effects seen with chloroquine occurred when tat was produced intracellularly. After transient transfection of HeLa cells with an HIV-LTR plasmid (p-167/+80; Rosen et al., 1985) , high levels of trans-activation were seen when tat was introduced by cotransfection with a tat expression plasmid (pSV2tat72), by scrape-loading purified tat, or by treatment with tat and chloroquine (Table 1) . However, expression from the HIV-LTR containing a mutant TAR site (p-167/+21; Rosen et al., 1985) or from the SV40 early promoter (pSV2-CAT Gorman et al., 1982) was not stimulated when tat was introduced by these methods. Thus, introducing purified tat by scrape-loading or by uptake with chloroquine appears to trans-activate the HIV-LTR by the same mechanism that occurs when tat is produced intracellularly. Chloroquine had no effect when tat was produced intracellularly:
chloroquine treatment of HL3Tl cells transiently transfected with pSV2tat72 showed no additional Pans-activation (data not shown).
Other cell lines were also tested for tat uptake and for Pans-activation after scrape-loading (data not shown). Jurkat T cells transfected with pHIV-CAT showed significant trans-activation when tat was later added to the medium and showed further stimulation in the presence No activity was seen with tat alone. Since the basal expression of CAT was low in this cell line, a severalfold increase in CAT activity would still have been undetectable.
To measure cellular uptake directly, HL3Tl cells were treated with 1251-labeled tat in the presence or absence of chloroquine, and the amount of radioactive tat present in various cellular fractions was determined.
Within 6 hr af- ter treating cells with tat and chloroquine, a significant amount of radioactive tat (about 3% of the total) had been taken up by the cells, and most of this (>80%) was localized to the nuclear fraction ( Figure 5A ). Trypsin-sensitive counts, presumably representing tat bound to the cell surface, remained relatively constant and by 12 hr were less than 20% of the counts found in the nucleus ( Figure 5A ). Nuclear extracts were run on an SDS gel, and a readioactive band comigrating with intact tat was readily apparent (Figure 58 ). Cells treated with tat but without chloroquine showed similar kinetics of uptake and nuclear localization when assayed by counting the cellular fractions but only degraded tat was seen on the gel ( Figure 5B ). Thus chloroquine appears to stabilize tat to proteolysis.
Discussion

Our experiments
show that cells grown in tissue culture can take up purified tat protein and that this protein can subsequently trans-activate the HIV-1 promoter. liansactivation is enhanced by chloroquine and can be detected at nanomolar tat concentrations in the presence of chloroquine.
Tat appears to be localized to the nucleus fol- In (A) and(C). the medium was replaced after 24 hr, and CAT activity was assayed after 80 hr. (0) and cytoplasmic (0) fractions were measured, and trypsin-sensitive counts (0) present after rinsing were presumed to be tat bound to the cell surface. (E) Nuclear fractions from cells treated with tat in the absence (-) or presence (+) of chloroquine for the times indicated were resuspended in SDS-gel loading buffer and run on a 15% SDS-polyacrylamide gel. Radiolabeled tat is shown in the first lane; some counts remamed at the top of the gel, and a small amount of the tat dimer was seen.
lowing uptake. Although many experiments are necessary to test the biological significance and the mechanism of uptake, these observations raise the possibility of an unexpected new aspect of tat action. In essence, tat might act as a viral growth factor. Tat, released into the serum by lysis of infected cells, might be taken up by other cells, causing rrans-activation of the HIV promoter in cells harboring latent virus or causing altered expression of cellular genes. Since AIDS patients do show antibodies to tat (Arya and Gallo, 1986; Barone et al., 1986; Aldovini et al., 1986; Franchini et al., 1987) , tat is probably present extracellularly at some time. If cellular uptake is important in vivo, this will have important implications for drug design. Our results may also raise new questions about the connectio? between AIDS and malaria. The spread of AIDS has been especially rapid in those areas of tropical Africa that have a high incidence of malaria (Greenberg et al., 1988) , and chloroquine has frequently been used in the chemotherapy of malaria (Goodman et al., 1985) . Is it conceivable that chloroquine could enhance tat transactivation and increase the chance of activating latent HIV in certain cell types or under certain growth conditions?
Experimental Procedures
Bacterial Expression and Purification of Tat Two plasmids were constructed to produce the tat protem in E. COII; one expresses amino acids l-86 (the entire coding sequence) and the other expresses the first coding exon of tat (residues 1-72). It is known that the second exon is not required for activity (Cullen, 1986; Muesing et al., 1967; Sodroski et al., 1985a) . Synthetic tat genes were constructed and ligated into the Ndel site of PET-3a, a plasmid that uses a strong bacteriophage T7 promoter to express cloned genes (Studier and Moffat, 1986; Rosenberg et al., 1987) . The resulting plasmids, ptat72 and ptat66, express tat (residues l-72 or l-66, respectively) as 1%~5% of total E. coli protein. 1966 ) and purified essentially as described (Frankel et al., 1966a) except that tat was extracted from the polyethyleneimine pellet with 10% ammonium sulfate instead of 700 mM KCI. and the S-Sepharose chromatography was eliminated.
Cell Culture and Scrape-Loading A HeLa cell line containing an integrated LTR-CAT plasmid (HLSTl; Wright et al., 1966; Felber and Pavlakis, 1968) was used for most experiments.
We expected this line to give maximum sensitivity In the CAT assay as each cell contains the LTR-CAT. HeLa, HLBTl. and VNHIV-CAT (Mosca et al., 1987) cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS). Jurkat T cells were grown in RPM1 1640 medium with 10% FCS. For scrape-loading, HeLa, HLSTI, or VNHIV-CAT cells were grown to about 50% confluency on 60 mm dishes in 5 ml medium at 37oC. Medium was removed, cells were washed with phosphate-buffered saline (PBS) containing 1 mM CaC12 and 0.5 mM MgClp, and fresh medium was added along with the purified tat protein. (Without washing, tat was degraded by trypsin that remained from splitting cells.) Cells were scraped from the dish using a rubber policeman and were resuspended as evenly as possible. Medium was replaced after 24 hr and cells were incubated at 37% until assayed.
Transient
Transfection, Plasmids, and CAT Assays DNAs (500 ng of p-167/+80, p-167/+21, pSVZtat72, or pSV2-CAT per 60 mm dish) were transfected into HeLa cells by lipofection (Felgner et al., 1987) for 3 hr. Jurkat T cells (IO7 cells) were transfected with 5 pg of pHIV-CAT using DEAE-dextran (Ausubel et al., 1987) . pHIV-CAT is identical to the pU3R-III plasmid (Sodroski et al., 1965b) . pSV2iat72 was constructed by replacing the dihydrofolate reductase gene from pSV2-dhfr (Subramani et al., 1981) with the synthetic gene for tat (residues l-72) from ptat72. Tat expression in this plasmid is controlled by the SV40 early promoter. CAT activity was assayed as described (Gorman et al., 1962) . Unacetylated and acetylated forms of 14C chloramphenicol were separated by thin-layer chromatography (TLC) and were quantitated by cutting the spots from TLC plates and counting by liquid scintillation.
Uptake of 1251-Labeled Tat Purified tat (residues l-72) was labeled with lz51 by treating 500 pg of protein with 0.5 mCi lz51 and IODO-BEADS (Pierce) in 0.1 M Tris-HCI (pH 7.5) at room temperature for 5 min. The sample was dialyzed to remove unreacted jz51. The specific activity was approximately lo6 cpm/pg protein. HL3T1 cells (2 x 106cells per dish) were treated with 5 vg radioactive tat in the presence or absence of 100 NM chloroquine. Medium was removed at various times, cells were washed with PBS+EOTA, and cells were trypsinized for 10 min. Pancreatic trypsin inhibitor was added (5 &ml), cells were chilled to 4X, centrifuged at 1000 x g. and the supernatant was saved. The cell pellet was washed twice with serum-free DMEM, once with PBS, and nuclei were isolated by.lysis in 0.5% NP-40 as described (Ausubel et al., 1987) . lz51 was counted using an LKB gamma counter.
